Clinical Trial Update: Randomized, Double-Blind, Placebo-Controlled Pilot Study on the Safety and Effectiveness of LUCEMYRA During an Opioid Taper in Treatment of Withdrawal [Phase 2]

View source ↗

Summary

A Phase 2 randomized, double-blind, placebo-controlled pilot study evaluating LUCEMYRA (lofexidine) during opioid taper in withdrawal was terminated; results we…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Withdrawal

Drugs mentioned

• LUCEMYRA (LOFEXIDINE HYDROCHLORIDE)

Snippet

Sponsor: USWM, LLC (dba US WorldMeds) | Conditions: Opioid Withdrawal (Disorder) | Phase 2 | Status: TERMINATED | Results posted: 2024-10-21